Neovasc regains Nasdaq listing compliance
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
Neovasc Inc. is no longer in violation of Nasdaq's listing requirements.
The specialty cardiovascular medical device company regained compliance after its stock price hovered above $1 for 10 consecutive days.